Literature DB >> 17406300

Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.

Ganesan Vaidyanathan1, Michael R Zalutsky.   

Abstract

A procedure for the synthesis of N-succinimidyl 3-iodobenzoate labeled with any iodine isotope ([*I]SIB), which is an agent used in the radioiodination of proteins and peptides, from its tin precursor N-succinimidyl 3-(tri-n-butylstannyl)benzoate (STB) is described. Also included are protocols for the synthesis of an unlabeled standard of SIB and the tin precursor. Radioiododestannylation of STB using tert-butylhydroperoxide as the oxidant gives [*I]SIB in 80% radiochemical yields. The total time for the synthesis of [*I]SIB from STB is approximately 95 min. Use of [*I]SIB yields radioiodinated proteins that are considerably more stable in vivo than those radioiodinated by the direct electrophilic method.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406300     DOI: 10.1038/nprot.2006.99

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  17 in total

1.  Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy.

Authors:  Alexey V Ulasov; Yuri V Khramtsov; Georgiy A Trusov; Andrey A Rosenkranz; Eugene D Sverdlov; Alexander S Sobolev
Journal:  Mol Ther       Date:  2010-11-02       Impact factor: 11.454

2.  Labeling Monoclonal Antibody with α-emitting 211At at High Activity Levels via a Tin Precursor.

Authors:  Ganesan Vaidyanathan; Oscar R Pozzi; Jaeyeon Choi; Xiao-Guang Zhao; Shawn Murphy; Michael R Zalutsky
Journal:  Cancer Biother Radiopharm       Date:  2020-02-28       Impact factor: 3.099

3.  Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6-[18F]Fluoronicotinate Resulting in High Tumor-to-Kidney Ratios.

Authors:  Zhengyuan Zhou; Darryl McDougald; Nick Devoogdt; Michael R Zalutsky; Ganesan Vaidyanathan
Journal:  Mol Pharm       Date:  2018-11-28       Impact factor: 4.939

4.  Generation of novel radiolabeled opiates through site-selective iodination.

Authors:  Susruta Majumdar; Maxim Burgman; Nathan Haselton; Steven Grinnell; Julia Ocampo; Anna Rose Pasternak; Gavril W Pasternak
Journal:  Bioorg Med Chem Lett       Date:  2011-05-08       Impact factor: 2.823

5.  Development and Preliminary Evaluation of TFIB, a New Bimodal Prosthetic Group for Bioactive Molecule Labeling.

Authors:  Emilie M F Billaud; Aurélien Vidal; Amélie Vincenot; Sophie Besse; Bernadette Bouchon; Eric Debiton; Elisabeth Miot-Noirault; Imen Miladi; Latifa Rbah-Vidal; Philippe Auzeloux; Jean-Michel Chezal
Journal:  ACS Med Chem Lett       Date:  2014-11-24       Impact factor: 4.345

6.  Synthesis and pharmacological characterization of [(125)I]MRS1898, a high-affinity, selective radioligand for the rat A(3) adenosine receptor.

Authors:  Zhan-Guo Gao; Bao Teng; Haitao Wu; Bhalchandra V Joshi; Gary L Griffiths; Kenneth A Jacobson
Journal:  Purinergic Signal       Date:  2008-06-05       Impact factor: 3.765

7.  SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.

Authors:  G Vaidyanathan; B J White; D J Affleck; X G Zhao; P C Welsh; D McDougald; J Choi; M R Zalutsky
Journal:  Bioorg Med Chem       Date:  2012-10-29       Impact factor: 3.641

8.  Synthesis and pharmacological characterization of [(125)I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor.

Authors:  John A Auchampach; Elizabeth T Gizewski; Tina C Wan; Sonia de Castro; Garth G Brown; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2009-11-14       Impact factor: 5.858

9.  Study of efficiency of the modular nanotransporter for targeted delivery of photosensitizers to melanoma cell nuclei in vivo.

Authors:  T A Slastnikova; A A Rosenkranz; T N Lupanova; P V Gulak; N V Gnuchev; A S Sobolev
Journal:  Dokl Biochem Biophys       Date:  2012-11-07       Impact factor: 0.788

10.  Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Pavel V Gulak; Raymond M Schiffelers; Tatiana N Lupanova; Yuri V Khramtsov; Michael R Zalutsky; Alexander S Sobolev
Journal:  Int J Nanomedicine       Date:  2012-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.